Concomitant use of anabolic androgen steroids and cabotegravir/rilpivirine leading to virological failure and development of two-class resistance

AIDS. 2024 Sep 1;38(11):1728-1729. doi: 10.1097/QAD.0000000000003959. Epub 2024 Aug 1.

Authors

David Burger¹, Eva Wttewaal², Piter Oosterhof^{1

3}, Janneke Stalenhoef²

Affiliations

¹ Department of Pharmacy, Radboud Institute for Medical Innovations (RIMI), Radboud UMC, Nijmegen.
² Department of Internal Medicine.
³ Department of Clinical Pharmacy, OLVG, Amsterdam, the Netherlands.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anti-HIV Agents* / therapeutic use
Diketopiperazines
Drug Resistance, Viral
HIV Infections* / drug therapy
Humans
Male
Middle Aged
Pyridones* / therapeutic use
Rilpivirine* / therapeutic use
Testosterone Congeners
Treatment Failure*

Substances

Pyridones
Anti-HIV Agents
cabotegravir
Rilpivirine
Testosterone Congeners
Diketopiperazines